Schroder Investment Management Group
VNDA icon

Schroder Investment Management Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Schroder Investment Management Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-307,176
Closed -$1.45M – 1265
2025
Q2 		$1.45M Sell
307,176
-359,285
-54% -$1.57M ﹤0.01% 954
2025
Q1 		$3.13M Sell
666,461
-371,559
-36% -$1.73M ﹤0.01% 845
2024
Q4 		$4.96M Hold
1,038,020
– – ﹤0.01% 772
2024
Q3 		$4.85M Sell
1,038,020
-117,407
-10% -$629K 0.01% 789
2024
Q2 		$6.53M Buy
+1,155,427
New +$5.97M 0.01% 726

Other funds holding VNDA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return